Dr Mushtaq discusses one centre’s initial post-marketing experience with the fluocinolone acetonide intravitreal implant 0.19 mg. The implant demonstrated favourable outcomes and good patient acceptance.
Bushra Mushtaq, FRCS
Advertisement
Articles by Bushra Mushtaq, FRCS
Advertisement
Latest Updated Articles
- Real-world experience: Positive DME treatment outcomes observed with FAc implant at UK centre
Published: May 1st 2015 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
AAO 2025: Glaucoma laser surgery with Joel S. Schuman, MD, FACS
3
News from Orlando: AAO 2025 highlights research across all areas of eyecare
4
AAO 2025: Clinical outcomes of early vs delayed pegcetacoplan treatment in GA
5
.png "Optometry Times"){kind=logo}
